Phase I Study in Advanced Solid Tumors

Status:
Unknown status

Trial end date:
2013-06-01

Target enrollment:

Participant gender:

Dose escalating study of orally administered indibulin at twice daily schedule in subjects with solid tumors.

Phase 1

Ziopharm